663 results on '"RODVOLD, KEITH A."'
Search Results
2. Lessons Are Still Being Learned About Intrapulmonary Antibiotic Concentrations
3. Infectious Diseases: Bacteria
4. Infectious Diseases: Fungi, Viruses, and Mycobacteria
5. Drug-Food Interactions
6. Introduction to Drug-Drug Interactions
7. Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics
8. Authors’ Reply to De Sutter, De Waele, and Vermeulen: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”
9. Antibacterial Resistance Leadership Group: Open for Business
10. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects
11. Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung
12. Drug-Food Interactions
13. Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis
14. Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
15. 625. SPR206 Pharmacokinetics (PK) in Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) in Healthy Adult Subjects
16. Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
17. Telavancin: The Long and Winding Road From Discovery to Food and Drug Administration Approvals and Future Directions
18. EDITORIAL COMMENTARY: Improving Prescribers to Advance Antimicrobial Stewardship
19. Innovative approaches to optimizing the delivery of vancomycin in individual patients
20. Aminoglycoside dosing in patients by kidney function and area under the curve: the Sawchuk-Zaske dosing method revisited in the era of obesity
21. 1362: EVALUATION OF CLEARANCE EQUATIONS IN CONTINUOUS RENAL REPLACEMENT THERAPY WITH AN IN VITRO MODEL
22. Methicillin-Resistant Staphylococcus aureus Therapy: Past, Present, and Future
23. The Empirical Combination of Vancomycin and a β-Lactam for Staphylococcal Bacteremia
24. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects
25. Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment
26. Pharmacokinetics of Protease Inhibitors and Drug Interactions with Psychoactive Drugs
27. Vancomycin for Surgical Prophylaxis?
28. Pharmacodynamics of Lipoglycopeptides
29. Pharmacodynamics of Daptomycin
30. Vancomycin: We Can't Get There From Here
31. Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
32. Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
33. Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy
34. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers
35. Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update
36. Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia
37. Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia
38. Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid: Focus on Antifungal, Antitubercular and Miscellaneous Anti-Infective Agents
39. Validity of 2020 vancomycin consensus recommendations and further guidance for practical application
40. Vancomycin: Over 50 Years Later and Still a Work in Progress
41. Questions on Vancomycin Dosing
42. Executive summary with focus on pediatrics: therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society and the Society of Infectious Diseases Pharmacists
43. Efficacy and Tolerability of Extended-Interval Aminoglycoside Administration in Pediatric Patients
44. Pharmacokinetics and tissue distribution of orally administered lycopene in male dogs
45. National survey on continuous and extended infusions of antibiotics
46. Drug interactions involving anti-infective agents
47. List of Contributors
48. Antibiotic Drug Interactions
49. Dosage Adjustments for Antibacterials in Obese Patients: Applying Clinical Pharmacokinetics
50. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant enterococcus faecium. (Brief Report)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.